[Acquired hydrocele in the adult: sclerotherapy].
We report our experience in the treatment of hydrocele using sclerosant therapy in 50 patients with adult acquired hydrocele (AAH) or cord cyst (CC). The sclerosing agent utilized in all of the patients was quinacrine dihydrochloride (quinacrine) at a dose of 13.3 mg 50 cc aspirated volume. The results were assessed clinically, ultrasonographically and thermographically. The presence of multilocular cysts or incomplete aspiration of the liquid was the most frequent cause of failure. The results show a success rate of 85%; however, 18% required more than one treatment.
Castillo Jimeno
J M
JM
Servicio de Urología, Hospital Virgen del Carmino, Pamplona, España.
González de Garibay
A S
AS
Sebastían Borruel
J L
JL
Valdivia Uría
J G
JG
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001831:Body Temperature; D003560:Cysts / Q000000981:diagnostic imaging / Q000628:therapy*; D005069:Evaluation Studies as Topic; D006801:Humans; D008297:Male; D008875:Middle Aged; D009920:Orchitis / Q000209:etiology; D011796:Quinacrine / Q000009:adverse effects / Q000627:therapeutic use; D012597:Sclerosing Solutions / Q000009:adverse effects / Q000627:therapeutic use; D015911:Sclerotherapy / Q000009:adverse effects; D013085:Spermatic Cord / Q000098:blood supply / Q000000981:diagnostic imaging; D006848:Testicular Hydrocele / Q000000981:diagnostic imaging / Q000628:therapy*; D014463:Ultrasonography
D012597:Sclerosing Solutions; D011796:Quinacrine
Hidrocele adquirido del adulto: escleroterapia.